Listar por autor "Anguita, Manuel"
Mostrando ítems 21-31 de 31
-
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study
González-Manzanares, Rafael; Anguita-Gámez, María; Muñiz, Javier; Barrios, Vivencio; Gimeno-Orna, José Antonio; Pérez, Antonio; Rodríguez-Padial, Luis; Anguita, Manuel (Springer, 2024-07-16)[Abstract] Background: Type 2 diabetes (T2D) patients have an increased risk of heart failure (HF). There are limited data on the association between HF and T2D in specific healthcare settings. This study sought to ... -
Prevalence of atrial fibrillation in Spain: OFRECE Study results
Gómez Doblas, Juan José; Muñiz, Javier; Alonso, Joaquin J; Rodríguez-Roca, Gustavo; Lobos, José María; Awamleh García, Paula; Permanyer-Miralda, Gaietá; Chorro, Francisco Javier; Anguita, Manuel; Roig, Eulàlia (Elsevier, 2013-11-23)[Abstract] Introduction and objectives. Atrial fibrillation is associated with substantial morbidity and mortality and both its incidence and prevalence are high. Nevertheless, comprehensive data on this condition in Spain ... -
Prevalence of heart failure in the spanish general population aged over 45 years. the PRICE study
Anguita, Manuel; Crespo-Leiro, María Generosa; Teresa Galván, Eduardo de; Jiménez-Navarro, Manuel; Alonso-Pulpón, Luis; Muñiz, Javier (Elsevier, 2009-01-15)[Abstract] Introduction and objectives. Congestive heart failure is associated with substantial morbidity and mortality and both its incidence and prevalence are high. Nevertheless, comprehensive data on this condition in ... -
Prevalence of Stable Angina in Spain: results of the OFRECE Study
Alonso, Joaquin J; Muñiz, Javier; Gómez Doblas, Juan José; Rodríguez-Roca, Gustavo; Lobos, José María; Permanyer-Miralda, Gaietá; Anguita, Manuel; Chorro, Francisco Javier; Roig, Eulàlia (Elsevier, 2015-02-17)[Abstract] Introduction and objectives. The objective of the OFRECE study was to estimate the prevalence of stable angina in Spain. This prevalence is currently unknown, due to a lack of recent studies and to changes in ... -
Quality of anticoagulation with vitamin K antagonists
Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ... -
Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: data from FANTASIIA Registry
Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Camacho Siles, José; Quesada, María Angustias; Ruiz Ortiz, Martín; Marín, Francisco; Martínez-Sellés, Manuel; Bertomeu, Vicente; Lip, Gregory; Cequier Fillat, Angel; Badimón, Lina (Wiley, 2018-02-09)[Abstract] Background. Anticoagulation control in patients with atrial fibrillation (AF) has a multidisciplinary approach although is usually managed by general practitioners (GP) or haematologists. The aim of our study ... -
Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, Marco; Esteve-Pastor, María Asunción; Rivera-Caravaca, José Miguel; Roldán, Vanessa; Roldán Rabadán, Inmaculada; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Elsevier, 2021-07-23)[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ... -
Relationship of Adverse Events to Quality of Anticoagulation Control in Atrial Fibrillation Patients With Diabetes: Real-World Data From the FANTASIIA Registry
García-Fernández, Amaya; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu- Martínez, Vicente; Badimón, Lina; Otero, Déborah; Anguita, Manuel; Lip, Gregory; Marín, Francisco (Taylor & Francis Group, 2020-06-17)[Abstract] Background: Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. Purpose: To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF ... -
Satisfaction with medical care in patients with atrial fibrillation treated with vitamin k antagonists versus new oral anticoagulants
Anguita, Manuel; Marín, Francisco; Roldán, Inmaculada; Cequier, Ángel; Bertomeu, Vicente; Muñiz, Javier (Elsevier, 2015-04-27) -
Structural heart disease in anticoagulated patients with nonvalvular atrial fibrillation: prevalence and clinical profile in a spanish sample
Ruiz Ortiz, Martín; Roldán, Inmaculada; Bertomeu, Vicente; Muñiz, Javier; Marín, Francisco; Anguita, Manuel (Elsevier, 2016-07-27) -
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...